2BBBullish & Bearish
Health Care

ImmuCell Corporation (ICCC) Stock Score & Signals

ImmuCell Corporation (ICCC) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 31 out of 100.

2BB score and signals

ImmuCell Corporation’s current 2BB score is 31 out of 100, built from the signal categories below.

SignalScoreReading
Activity18Very Low
Momentum36Weakening
Financial strength70Strong
Quality80Very Strong
Risk39Low

Company facts

CEOMichael F Brigham
HeadquartersPortland, Maine, United States
Founded1982
Employees73
52-week range$4.52 – $12.10

Recent earnings

Report dateEPS actualEPS estimateRevenue actualRevenue estimate
2026-11-11
2026-08-13
2026-05-140.21$10.36M
2026-03-04-0.31$7.63M